New Insights on Treating Infantile Epilepsy Spasms Syndrome
⚠️ Infant dosing/safety: medication and diet decisions for infants require individualized medical guidance.
Source: Epilepsia open
Summary
Researchers studied infantile epilepsy spasms syndrome (IESS), a serious condition that affects about 3 in 10,000 newborns in the U.S. IESS is marked by clusters of seizures, unusual brain activity, and delays in development. The study used a rodent model to better understand the mechanisms behind IESS and to test potential treatments, as current medications have limited effectiveness and can cause side effects.
The key findings from the study indicate that certain treatments, like AQB-565, may help reduce seizures while causing fewer side effects compared to traditional medications. The research also revealed differences in brain proteins and activity patterns between animals with and without spasms. This suggests that factors like prenatal stress could increase the risk of IESS, and that treatments might need to be tailored based on individual characteristics, including sex.
These findings are important because they highlight the complexity of IESS and the need for more effective treatments. While the rodent model provides valuable insights, it is essential to remember that results in animals do not always translate directly to humans. More research is needed to develop targeted therapies that can improve the lives of those affected by IESS.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.
